Dietary Choline Intake During Pregnancy and Congenital Heart Defects in a Chinese Population
Nutrients · 2025
DOI: 10.3390/nu18010126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Yue-Hua Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China. Hauptthemen laut MEDLINE: Heart Defects, Congenital, Choline, Diet, Maternal Nutritional Physiological Phenomena. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Plan in Shaanxi Province of China, Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province.
Abstract (Originalsprache)
Background/Objectives: The impact of choline on congenital heart defects (CHDs) in humans remains unclear. This study aimed to investigate the associations between maternal dietary intakes of choline and choline derivatives during pregnancy and CHD.
Methods
This case–control study included 474 cases and 948 controls from hospitals in Northwest China. Pregnant women admitted for delivery were enrolled and completed a validated food frequency questionnaire to assess their dietary intake during pregnancy. A standardized questionnaire was also administered to collect additional pregnancy-related information. Mixed logistic regression models were used to estimate ORs (95%CIs) for CHD in association with choline intake.
Results
Higher intakes of total choline, phosphatidylcholine, sphingomyelin, glycerophosphocholine, and phosphocholine in pregnancy were associated with reduced risks of total CHD, ventricular septal defects, and atrial septal defects, with all trend tests showing statistical significance (all p < 0.05). The ORs (95%CIs) of total CHD, comparing the highest with the lowest tertiles of intake, were 0.38 (0.24–0.61) for total choline, 0.51 (0.38–0.70) for phosphatidylcholine, 0.37 (0.26–0.51) for sphingomyelin, 0.34 (0.21–0.53) for glycerophosphocholine, and 0.53 (0.34–0.82) for phosphocholine. The inverse associations remained unchanged according to maternal age, work, education, parity, passive smoking, anemia, medication use, or folate/iron supplements use in pregnancy; however, these associations appeared to be more pronounced among pregnant women in urban areas.
Conclusions
Higher maternal intake of dietary choline during pregnancy may be associated with a lower risk of CHD. Promoting choline intake in pregnant women could serve as a potential strategy for the primary prevention of fetal CHD in China.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
- Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University, Ministry of Education, Xi'an 710061, China.
ORCID-Profile: Xin Liu
Förderung
- National Natural Science Foundation of China
- Key Research and Development Plan in Shaanxi Province of China
- Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province
Zitieren
APA
Li, Y. H., Xiao, Z., Guo, R., Rekemubieke, B., Hu, W., Liu, X., & Yang, J. (2025). Dietary Choline Intake During Pregnancy and Congenital Heart Defects in a Chinese Population. Nutrients. https://doi.org/10.3390/nu18010126
Vancouver
Li YH, Xiao Z, Guo R, Rekemubieke B, Hu W, Liu X, et al. Dietary Choline Intake During Pregnancy and Congenital Heart Defects in a Chinese Population. Nutrients. 2025. doi:10.3390/nu18010126
BibTeX
@article{Li2025,
author = {Li, Yue-Hua and Xiao, Ziqi and Guo, Rui and Rekemubieke, Baligen and Hu, Wanting and Liu, Xin and Yang, Jiaomei},
title = {Dietary Choline Intake During Pregnancy and Congenital Heart Defects in a Chinese Population},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu18010126}
}
EUVIMED